HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enterohemolysin operon of Shiga toxin-producing Escherichia coli: a virulence function of inflammatory cytokine production from human monocytes.

Abstract
Shiga toxin-producing Escherichia coli (STEC) is associated with hemolytic uremic syndrome (HUS). Although most clinical isolates of STEC produce hemolysin (called enterohemolysin), the precise role of enterohemolysin in the pathogenesis of STEC infections is unknown. Here we demonstrated that E. coli carrying the cloned enterohemolysin operon (hlyC, A, B, D genes) from an STEC human strain induced the production of interleukin-1beta (IL-1beta) through its mRNA expression but not tumor necrosis factor-alpha from human monocytes. No IL-1beta release was observed with an enterohemolysin (HlyA)-negative, isogenic E. coli strain carrying a mutation in the hlyA gene. The data suggest that enterohemolysin, a pore-forming toxin, induces the production of IL-1beta, which is one of serum risk markers for HUS.
AuthorsIkue Taneike, Hui-Min Zhang, Noriko Wakisaka-Saito, Tatsuo Yamamoto
JournalFEBS letters (FEBS Lett) Vol. 524 Issue 1-3 Pg. 219-24 (Jul 31 2002) ISSN: 0014-5793 [Print] England
PMID12135770 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • Escherichia coli Proteins
  • Hemolysin Proteins
  • Interleukin-1
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • enterohemolysin
  • Shiga Toxin
Topics
  • Base Sequence
  • DNA Primers
  • Escherichia coli (genetics, metabolism, pathogenicity)
  • Escherichia coli Proteins
  • Hemolysin Proteins (genetics)
  • Hemolysis
  • Humans
  • Interleukin-1 (biosynthesis, genetics)
  • Monocytes (metabolism, microbiology)
  • Operon
  • Phenotype
  • RNA, Messenger (genetics)
  • Shiga Toxin (biosynthesis)
  • Tumor Necrosis Factor-alpha (biosynthesis, genetics)
  • Virulence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: